» Articles » PMID: 20686478

Prescription Drug Abuse: Insight into the Epidemic

Overview
Publisher Wiley
Specialty Pharmacology
Date 2010 Aug 6
PMID 20686478
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The emergence of clinically efficacious prescription drugs to treat pain, anxiety, and learning disorders is accompanied by the potential for nonmedical use. Prescription drug abuse has become a modern-day epidemic in the United States and is now second only to marijuana use across all age groups. This article reviews the various data collection, analysis, and reporting systems that have been developed in response to the growing concern for nonmedical prescription drug use. The terminology used to categorize prescription drugs that are abused and the various definitions for abuse, misuse, and nonmedical use are discussed. The epidemiology of nonmedical prescription drug use and an overview of each class of prescription drug that is at risk for nonmedical use are presented along with details of specific drugs that are associated with significant morbidity or mortality.

Citing Articles

The prevalence of Tramadol abuse and associated factors among Hawassa University students, Hawassa, Ethiopia.

Legasse A, Tamiru W, Mohammed F, Ataro G PLoS One. 2025; 20(3):e0318634.

PMID: 40063646 PMC: 11892866. DOI: 10.1371/journal.pone.0318634.


Substance use patterns among a global sample of transgender and non-binary people during the COVID-19 pandemic.

Garrison-Desany H, Childress C, McConico N, Jarrett B, Howell S, Glick J BMC Glob Public Health. 2024; 1(1):16.

PMID: 39681913 PMC: 11622945. DOI: 10.1186/s44263-023-00014-5.


Suspected inappropriate use of prescription and non-prescription drugs among requesting customers: A Saudi community pharmacists' perspective.

Yasmeen A, Syed M, Alqahtani S, Syed N, Meraya A, Wazaify M Saudi Pharm J. 2023; 31(7):1254-1264.

PMID: 37273264 PMC: 10238264. DOI: 10.1016/j.jsps.2023.05.009.


A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases.

Chiappini S, Vickers-Smith R, Guirguis A, Corkery J, Martinotti G, Schifano F Pharmaceuticals (Basel). 2022; 15(5).

PMID: 35631391 PMC: 9146999. DOI: 10.3390/ph15050565.


Nonmedical use of prescription drugs: A comparison between intoxication-oriented and other nonmedical users.

Piispa I, Karjalainen K, Karttunen N Nordisk Alkohol Nark. 2022; 39(1):64-75.

PMID: 35308467 PMC: 8899273. DOI: 10.1177/14550725211018082.